Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Sleep & recovery
Research brief

Sleep disturbance model for rural Chinese older adults with mild cognitive impairment

In a cross-sectional survey of 1,049 rural Chinese adults aged 60+ with mild cognitive impairment, 54.2% had sleep disturbance. Sex, hypertension, self-rated health and depression were independent predictors in a nomogram with good discrimination (AUC 0.759). [1]

Automatic summary · not editorially reviewed

The key findings

  1. The study included 1,049 rural older adults aged 60 or older with mild cognitive impairment in Shandong Province, China. [1]

  2. Sleep quality was assessed with the Pittsburgh Sleep Quality Index in a cross-sectional design. [1]

  3. Sleep disturbance prevalence was 54.2%, and the nomogram reached an AUC of 0.759. [1]

The source at a glance

Study type / format
Cross-sectional study using 2024 baseline survey data.
Population / context
1,049 rural older adults aged 60 or older with mild cognitive impairment in Shandong Province, China.
Summary based on
Study abstract
Original publication
October 20, 2026

Sleep disturbance in rural older adults with MCI

The researchers wanted to build and test a risk assessment model for sleep disturbance among rural older adults with mild cognitive impairment (MCI), a mild decline in memory and thinking. The aim was to support early screening and targeted intervention. The study population was 1,049 rural adults aged 60 or older with MCI in Shandong Province, China.

Supporting source [1]

Cross-sectional survey with questionnaires and health exams

This was a cross-sectional study using data from the 2024 baseline survey of the Active Aging Cohort in Rural Areas. Information on demographics, lifestyle, disease history and psychological factors came from face-to-face questionnaires and health examinations. Sleep quality was measured with the Pittsburgh Sleep Quality Index. Statistical models identified independent predictors, which were combined into a nomogram, a visual scoring tool. Model performance was checked with several curve-based methods and internal bootstrap validation.

Supporting source [1]

54.2% prevalence; four predictors; good discrimination

Sleep disturbance was present in 54.2% of participants. Sex, hypertension, self-rated health and depression were independent predictors. The nomogram showed good discrimination (AUC = 0.759, 95% confidence interval 0.731–0.778) and calibration, and internal validation confirmed robustness. Because the design is cross-sectional, these are associations, not causes, and the timing of predictors relative to sleep problems is not established. The model was internally validated only, so performance in other populations is unknown.

Supporting source [1]

How to interpret this

Abstract only; the full text was not reviewed. Cross-sectional design means associations, not causes. Only internal bootstrap validation is reported; external validation and follow-up are not described.

Based on the study abstract; the full paper, tables and supplementary data were not reviewed.

Source & supporting passages

[1]
Construction and validation of a predictive model for sleep disorders among rural older adults with mild cognitive impairment.

Yang T, Chi J, Song J, Yan L, Li W, Xu Z, Li H, Dai C, Leng M. · europepmc.org · October 20, 2026

Read the quoted passagesIn the language of the original source
  1. Finding 1 ↑

    1,049 rural older adults aged ≥ 60
  2. Finding 2 ↑

    Sleep quality was assessed using the Pittsburgh
  3. Finding 3 ↑

    prevalence of sleep disturbance was 54.2%

AI-assisted summary with linked source passages. No independent editorial or clinical review.

Our editorial method

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…